Form 4: Labcorp CEO Adam Schechter Reports Stock Transactions

Labcorp CEO Adam Schechter reports the vesting and subsequent tax withholding of restricted stock units.

Summary

• On February 6, 2025, Adam Schechter, President & CEO of Labcorp Holdings Inc., had 4,460 Restricted Stock Units vest, which converted into common stock.
• Following the vesting, 1,240 shares were withheld to cover tax obligations at a price of $247.74 per share.
• On February 7, 2025, an additional 3,250 Restricted Stock Units vested and converted into common stock.
• Following the vesting, 1,345 shares were withheld to cover tax obligations at a price of $246.27 per share.
• After these transactions, Schechter directly owns 92,566 shares of Labcorp common stock and 15,132 Restricted Stock Units.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine disclosure of stock transactions related to executive compensation.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies to align the interests of executives with those of shareholders.
• The vesting schedules and tax withholding practices observed in this filing are typical for executive compensation packages in the healthcare industry.
• Comparable companies such as Quest Diagnostics also regularly report similar Form 4 filings for their executives.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, employees, customers, suppliers, or creditors.
• The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

Keywords

Labcorp, Adam Schechter, Restricted Stock Units, Common Stock, Form 4, Insider Trading, Tax Withholding, Beneficial Ownership